The effect of Ginger consumption on inflammation and blood pressure in patients with type 2 diabetes mellitus

Phase 2

• Conditions: type 2 diabetese melitus.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT201204159472N1
• Lead Sponsor: Vice-chancellor for Research, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

patients with type 2 diabetes; Diabetes duration of at least 1 years with 0ral medications; 30-70 years ages; Hb A1c :7-10% ; BMI between 20-35; not smoking and alcohol; not pregnancy and lactation. exclusion criteria: Patient unwillingness to continue with the plan; changes in type or dose of medication; Changes in diet or physical activity every day; taking less than 80% of supplements given to patients at baseline(the compaliance lower than %80); consumption of contraceptives,multivitamins and antioxidant supplements; renal , hepatic , thyroid, parathyroid diseases, cancer,inflammation

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum CRP. Timepoint: before and after 3 month of intervention. Method of measurement: turbidometry.;Plasma PGE2. Timepoint: before and after 3 month of intervention. Method of measurement: ELISA.;Serum TNF alfa. Timepoint: before and after 3 month of intervention. Method of measurement: ELISA.;Systolic and diastolic blood pressure. Timepoint: before and after 3 month of intervention. Method of measurement: sphygmomanometer.

Secondary Outcome Measures

Name	Time	Method
FBS. Timepoint: before and after 3 month of intervention. Method of measurement: colorimetry.;Insulin. Timepoint: before and after 3 month of intervention. Method of measurement: ELISA.;HbA1C. Timepoint: before and after 3 month of intervention. Method of measurement: Bronate Affinity.;HOMA-IR. Timepoint: before and after 3 month of intervention. Method of measurement: insulin × glucose / 22.5.;Choleserol. Timepoint: before and after 3 month of intervention. Method of measurement: colorimetry.;TG. Timepoint: before and after 3 month of intervention. Method of measurement: colorimetry.;LDL cholesterol. Timepoint: before and after 3 month of intervention. Method of measurement: colorimetry.;HDL cholesterol. Timepoint: before and after 3 month of intervention. Method of measurement: colorimetry.;Waist circumference. Timepoint: before and after 3 month of intervention. Method of measurement: meter.